Texas Yale Capital Corp’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,344	Closed	-$420K	–	457
2019 Q1	$420K	Buy	5,344 +2,806	+111%	+$221K	0.02%	421
2018 Q4	$215K	Buy	+2,538	New	+$215K	0.02%	394